The number of people getting treatment for pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) in France has been rising over the years. Among those who used such a treatment with Truvada or a generic equivalent between January 2016 and June 2021, 15.8 percent were younger than 25 and 1 percent were older than 65 years. During this period, most PrEP users in France were aged 26 to 35.
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you HIV/AIDS in France
Overview
4
Epidemiological data
7
- Premium Statistic Number of HIV diagnoses among men in France 2019, by region
- Premium Statistic Number of HIV diagnoses among women in France 2019, by region
- Premium Statistic New HIV diagnoses in France 2018, by transmission mode
- Premium Statistic Number of AIDS diagnoses among men in France 2019, by region
- Premium Statistic Number of AIDS diagnoses among women in France 2019, by region
- Premium Statistic Gross rate of patients covered by health insurance for HIV in France 2019, by gender
- Premium Statistic Gross rate of care for HIV/AIDS in France 2019, by age group
Prevention and screening
5
- Basic Statistic Frequency of condom use among sexually active people in France 2023
- Premium Statistic Number of condoms sold in France 2021, by region
- Premium Statistic Number of HIV self-tests sold in France 2021, by region
- Premium Statistic HIV testing in France 2019, by region
- Premium Statistic HIV test positivity rate in France 2019, by region
Pre-exposure prophylaxis
5
- Premium Statistic HIV prevention: PrEP initiations in France S1 2016-S1 2021
- Premium Statistic HIV prevention: PrEP users in France S1/2016-S1/2021
- Premium Statistic HIV prevention: PrEP initiations in France 2016-2021, by region
- Premium Statistic Gender distribution of PrEP users in France 2016-2021
- Premium Statistic Age distribution of PrEP users in France 2016-2021
Spending
5
- Premium Statistic Total HIV expenditure in France 2016
- Premium Statistic Social security expenses for HIV or AIDS in France 2019
- Premium Statistic Breakdown of social security expenses for HIV or AIDS in France 2019
- Premium Statistic Social security ambulatory care expenses for HIV or AIDS in France 2019, by type
- Premium Statistic Antiretroviral therapy expenditure for HIV in France 2014-2017
Further related statistics
15
- HIV-/AIDS-Prevention
- Total HIV/AIDS funding by the National Institutes for Health 2013-2025
- Colombia: HIV expenditure 2010-2013
- Mexico: HIV expenditure 2009-2015
- Brazil: new HIV cases among adults 2005-2017, by gender
- Brazil: PrEP users 2018, by sexual orientation
- Sub-Saharan Africa - HIV treatment cascade 2012
- Coverage of HIV testing and counseling for pregnant women by WHO region 2005-2013
- HIV death rate by age and gender 2013
- Gap between HIV diagnoses and treatment in the U.S. 2014
- HIV/AIDS spending from domestic and international sources by country 2013
- Estimated number of people living with HIV Sri Lanka 2000-2020
- Measures taken by schools and workplaces against the COVID-19 Spain 2020
- Industry revenue of “Wastewater treatment services“ in South Korea 2012-2024
- Industry revenue of “window treatment stores“ in Illinois 2012-2024
Further Content: You might find this interesting as well
Statistics
- HIV-/AIDS-Prevention
- Total HIV/AIDS funding by the National Institutes for Health 2013-2025
- Colombia: HIV expenditure 2010-2013
- Mexico: HIV expenditure 2009-2015
- Brazil: new HIV cases among adults 2005-2017, by gender
- Brazil: PrEP users 2018, by sexual orientation
- Sub-Saharan Africa - HIV treatment cascade 2012
- Coverage of HIV testing and counseling for pregnant women by WHO region 2005-2013
- HIV death rate by age and gender 2013
- Gap between HIV diagnoses and treatment in the U.S. 2014
- HIV/AIDS spending from domestic and international sources by country 2013
- Estimated number of people living with HIV Sri Lanka 2000-2020
- Measures taken by schools and workplaces against the COVID-19 Spain 2020
- Industry revenue of “Wastewater treatment services“ in South Korea 2012-2024
- Industry revenue of “window treatment stores“ in Illinois 2012-2024
ANSM. (November 30, 2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group [Graph]. In Statista. Retrieved June 01, 2024, from https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. "Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group." Chart. November 30, 2021. Statista. Accessed June 01, 2024. https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. (2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group. Statista. Statista Inc.. Accessed: June 01, 2024. https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/
ANSM. "Distribution of People Treated with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between January 2016 and June 2021, by Age Group." Statista, Statista Inc., 30 Nov 2021, https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/
ANSM, Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group Statista, https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/ (last visited June 01, 2024)
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by age group [Graph], ANSM, November 30, 2021. [Online]. Available: https://www.statista.com/statistics/1116573/hiv-aids-prep-users-france-age/